Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Grand River Continues to Expand Sterile Injectable Capabilities | Contract Pharma

What are you searching for?

Sign in
Videos

Grand River Continues to Expand Sterile Injectable Capabilities

President & CEO Tom Ross talks personnel growth and expansion plans

By: Betsy Louda

, Contract Pharma



Since their launch in 2011, Grand River Aseptic Manufacturing has been working with clients to develop and manufacture sterile, injectable drug products. 

Tom Ross, the company’s president and chief executive officer, spoke with Contract Pharma at CPhI North America 2018 about the exponential growth he has seen within his company, which started with 16 employees and is now up to 183. He also discussed a major expansion after closing on a large capital raise with Arlington Capital Partners.

The expansion will consist of a large fill/finsh facility with multiple cleanrooms, and will be over 40,000 sq. ft. Grand River has also recently acquired a new syringe filler, which is expected to go live at their facility in the summer of 2020.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics